Advancement of engineered bacteria for orally delivered therapeutics
Originally developed to regulate insulin resistance in people with type 2 diabetes, semaglutide (also known by certain drug names like Ozempic, Wegovy, and Rybelsus, the oral version) has officially gone mainstream so much so that its sometimes hard to get your hands on the medication
Lab testing helps determine whether B12 injections are appropriate for you
BPC-157 + TB500 Goal: Comprehensive joint, tendon, ligament, and muscle repair BPC-157: Stimulates collagen synthesis, improves angiogenesis, reduces inflammation
Here's what you need to know: Medicare Coverage (Effective Mid-2026) Following the November 2025 Trump administration agreements, Medicare will cover GLP-1 medications for obesity with: $50 monthly copay for eligible patients $245 government cost (down from $1,000+ list prices) Medicare Eligibility Requirements: BMI over 27 with prediabetes OR established cardiovascular disease, OR BMI over 30 with uncontrolled hypertension, kidney disease, or heart failure, OR BMI over 35 (severe obesity) Medicaid Coverage States can opt into $245 monthly pricing for all covered uses
